AB Sciex and University of Melbourne Partner on MS Workflow Studying Biopharmaceutical Metabolism
September 17, 2010
AB Sciex and University of Melbourne Partner on MS Workflow Studying Biopharmaceutical Metabolism
The technique, which is being developed on AB Sciex's QTRAP 5500 and TripleTOF 5600 machines, could help drugmakers better track the metabolism of their biopharmaceutical agents in vivo, improving studies of their efficacy and safety, said a researcher.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- BGI Aims to Expand Proteomics Services, Purchase 50-Plus New Mass Spectrometers
June 17, 2011 / ProteoMonitor - Tohoku U Spinoff Targeting Pharma Industry with SRM-MS Assays for ADMET Research
August 5, 2011 / ProteoMonitor - Hutch, Broad Teams Publish Comprehensive Methods for MS-Based Biomarker Discovery and Verification
July 29, 2011 / ProteoMonitor - Strong TripleTOF 5600 Sales Drive Mid-Teens Q2 Growth at AB Sciex
July 22, 2011 / ProteoMonitor - SERI Using TripleTOF 5600 to Validate Protein Biomarker for Dry Eye Syndrome
May 6, 2011 / ProteoMonitor